XML 63 R51.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Equity-Based Compensation (Details) - Schedule of Equity-Based Compensation Expense - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Schedule of Equity-Based Compensation Expense [Abstract]    
Research and development [1] $ 72 $ 110
Selling, general and administrative 1,041 834
Total equity-based compensation expense $ 1,113 $ 944
[1] Had the Company recorded the Management Contingent Share Plan within research and development and selling, general and administrative expense, then research and development would have been (reduced) increased by $(55) and $201 for the years ended December 31, 2023 and 2022, respectively, with the remaining (reduction) increase recognized within selling, general and administrative expense for the years ended December 2023 and 2022.